Phase I Study To Assess The Safety And Tolerability Of Olaparib In
Phase I study to assess the safety and tolerability of olaparib in ...
Phase I study to assess the safety and tolerability of olaparib in ...
(PDF) Phase I study to assess the safety and tolerability of olaparib ...
(PDF) Phase I study to assess the safety and tolerability of olaparib ...
Study on the Safety and Tolerability of Olaparib in Children and ...
(PDF) A Randomised Phase I Study to Assess the Safety, Tolerability and ...
(PDF) A Phase 1 Study to Assess the Safety, Tolerability and PK of ARRY ...
(PDF) A Phase I study to evaluate safety and tolerability of DTaP-IPV ...
(PDF) Safety and tolerability of the olaparib tablet formulation in ...
Phase I dose-escalation study to assess the safety, tolerability ...
Advertisement Space (300x250)
(PDF) Phase I dose-escalation study to assess the safety, tolerability ...
(PDF) A phase I trial to assess the safety, tolerability, PK and PD of ...
Phase I Study of Olaparib and Temozolomide in
Phase I and Pharmacologic Study of Olaparib in Combination with High ...
Exactis-03: A phase I trial of the combination of olaparib and ...
(PDF) Phase I clinical study of oral olaparib in pediatric patients ...
(PDF) A phase I study to evaluate the safety, tolerability ...
(PDF) A Phase I Combination Study of Olaparib with Cisplatin and ...
(PDF) A phase 1 evaluation of the safety and tolerability of niraparib ...
(PDF) A Phase 1 Open-Label Study to Assess the Tolerability, Safety ...
Advertisement Space (336x280)
Phase I study of olaparib plus gemcitabine in patients with advanced ...
(PDF) The efficacy and safety of olaparib in the treatment of cancers ...
(PDF) A Phase I/II Study to Assess the Safety, Tolerability ...
The efficacy and safety of olaparib in the treatment of cancers | CMAR ...
Phase I study of continuous olaparib capsule dosing in combination with ...
(PDF) Phase 1 Study to Assess Safety, Tolerability and Pharmacokinetics ...
EP216/#881 Safety and tolerability of olaparib in Indian patients with ...
A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokine ...
(PDF) A multicenter open-label phase I/II study to assess the safety ...
The efficacy and safety of olaparib in the treatment of cancers | CMAR ...
Advertisement Space (336x280)
Phase I/Ib study of olaparib and carboplatin in heavily pretreated ...
(PDF) Safety and tolerability of the poly(ADP-ribose) polymerase (PARP ...
(PDF) The safety, tolerability and pharmacokinetics of niraparib in ...
(PDF) A Phase 1 Study of the Safety, Tolerability, and Pharmacokinetics ...
(PDF) A multicenter, open label, Phase 1 study of the safety ...
A phase I, open-label, two-stage study to investigate the safety ...